Target intelligence / Profile preview

Kelch-like protein 27 (KLHL27)

Target
KLHL27
Molecular classification
Other (Kelch-like protein; BTB/POZ domain protein; member of the cullin 3 E3 ligase adaptor complex)
01

Overview

Kelch-like protein 27 (KLHL27), also known as intracisternal A particle-promoted polypeptide (IPP), is a member of the Kelch-like (KLHL) protein family, which collectively function as substrate adaptors for cullin 3 (CUL3)-based E3 ubiquitin ligase complexes[1][2][4][5]. Like other KLHL proteins, KLHL27 contains BTB/POZ, BACK, and Kelch domains that mediate protein–protein interactions, particularly linking substrates (such as actin) to the ubiquitination machinery for their modification or degradation[1][2]. KLHL27 is implicated in actin cytoskeleton organization and is highly expressed in some cancers, including breast cancer[2][4]. In cancer, potential interactions with proteins such as Hook2 (important for mitosis and cytokinesis) and Lig4 (involved in DNA repair) suggest contextual relevance, but no direct evidence currently supports its use as a therapeutic target or interaction with approved drugs[2][4]. **Note:** There is no evidence that KLHL27/IPP is a receptor, enzyme, transporter, or target of any approved or investigational drugs at this time. It is not currently considered a therapeutic target.

Other names
Intracisternal A particle-promoted polypeptideIPPactin-binding protein IPPkelch-like family member 27KLHL27Kelch-like protein 27
02

Biological functions

Organization of the actin cytoskeletonUbiquitination (likely as an E3 ligase adaptor)Protein–protein interactions
03

Disease associations

Cancer (upregulated in breast cancer; likely involved in gastrointestinal tumors as per potential substrates and interactors)Other (mutation/dysregulation in associated pathways may contribute to disease, but direct causal role is unclear)
04

Safety considerations

no known direct safety concerns or therapeutic challenges reported
05

Biomarkers

no well-established biomarkersKLHL27 expression reported elevated in some cancers

Beyond the preview

Go deeper on Kelch-like protein 27 (KLHL27).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelch-like protein 27 (KLHL27).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call